11. Myasthenia gravis Clinical trials / Disease details
Clinical trials : 315 / Drugs : 232 - (DrugBank : 77) / Drug target genes : 46 - Drug target pathways : 126
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01179893 (ClinicalTrials.gov) | March 2007 | 9/8/2010 | Intravenous Immunoglobulin and Plasma Exchange in Myasthenia Gravis | A Randomized Trial of Plasma Exchange vs. IVIG in the Treatment of Myasthenia Gravis | Myasthenia Gravid | Biological: IVIG;Procedure: PLEX | University Health Network, Toronto | Grifols Therapeutics Inc. | Completed | 18 Years | N/A | Both | 87 | Phase 4 | Canada |